JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Journal of Endocrinology (2002) 173, 517-523       DOI: 10.1677/joe.0.1730517
© 2002 Society for Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (28)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jonsson, L
Right arrow Articles by Schioth, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jonsson, L
Right arrow Articles by Schioth, H.
Journal of Endocrinology, Vol 173, Issue 3, 517-523
Copyright © 2002 by Society for Endocrinology


Articles

Food conversion is transiently affected during 4-week chronic administration of melanocortin agonist and antagonist in rats

L Jonsson, JO Skarphedinsson, GV Skuladottir, H Watanobe, and HB Schioth


The central melanocortin system is involved in the regulation of food intake and body weight. In this study, we investigated the effect of a 4-week intracerebroventricular infusion of the melanocortin receptor agonist MT-II and the selective melanocortin-4 receptor antagonist HS024 on food intake and body weight homeostasis. The MT-II-treated rats ate less and lost considerably more weight than the control rats during the first week of treatment. During the second and third week, they gained weight and, by the end of the treatment period, the weight gain was similar to that of the control rats. The HS024 treatment caused hyperphagia and development of obesity during the entire period. Extensive accumulations of fat and a sixfold increase in leptin levels were observed in the HS024-treated rats, as compared with controls, after the 4-week period. Food conversion ratio, defined as body weight increase relative to weight of ingested food, was clearly increased in the HS024-treated rats, while it was lowered in the MT-II-treated rats compared with controls. The effect on food conversion ratio was transient, being greatest for both experimental groups during the first week and it was then attenuated to reach the level of controls at the end of the study. The results suggest that long-term injection of exogenous melanocortin receptor active substances may have an important transient effect on food conversion.


This article has been cited by other articles:


Home page
J. Neurosci.Home page
L.-Y. Fu and A. N. van den Pol
Agouti-Related Peptide and MC3/4 Receptor Agonists Both Inhibit Excitatory Hypothalamic Ventromedial Nucleus Neurons
J. Neurosci., May 21, 2008; 28(21): 5433 - 5449.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Lee, A. Kim, S. C. Chua Jr., S. Obici, and S. L. Wardlaw
Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet
Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E121 - E131.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. P. Shearman, S.-P. Wang, S. Helmling, D. S. Stribling, P. Mazur, L. Ge, L. Wang, S. Klussmann, D. E. Macintyre, A. D. Howard, et al.
Ghrelin Neutralization by a Ribonucleic Acid-SPM Ameliorates Obesity in Diet-Induced Obese Mice
Endocrinology, March 1, 2006; 147(3): 1517 - 1526.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
I M Heid, C Vollmert, A Hinney, A Doring, F Geller, H Lowel, H-E Wichmann, T Illig, J Hebebrand, F Kronenberg, et al.
Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys
J. Med. Genet., April 1, 2005; 42(4): e21 - e21.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Bluher, M. Ziotopoulou, J. W. Bullen Jr, S. J. Moschos, L. Ungsunan, E. Kokkotou, E. Maratos-Flier, and C. S. Mantzoros
Responsiveness to Peripherally Administered Melanocortins in Lean and Obese Mice
Diabetes, January 1, 2004; 53(1): 82 - 90.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. L. Williams, R. R. Bowers, T. J. Bartness, J. M. Kaplan, and H. J. Grill
Brainstem Melanocortin 3/4 Receptor Stimulation Increases Uncoupling Protein Gene Expression in Brown Fat
Endocrinology, November 1, 2003; 144(11): 4692 - 4697.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. J. Kuo, A. A. Silva, and J. E. Hall
Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function
Hypertension, March 1, 2003; 41(3): 768 - 774.
[Abstract] [Full Text] [PDF]




HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society for Endocrinology.